`
Ace Inhibitor
Antihistamine
Antiplatelet
Antivival
Aminoglycosides
Beta Blocker
Calcium Antagonist
Cephalosporin
Coenzyme
Diaminopyvimidine
Loop Diuretic
Glucocorticoid
H2 Blocker
Haemostatic/
Fibronolytic
Lincosmide
Macrodile
Penicillin
Phenylacetic acid
Proton Pump Inhibitor
Statin
Quinolones

Untitled Document


N O R O C I N 400
( N O R F L O X A C I N U.S.P.)

Escherichia coli
THe main culprit of UTI


"Certain strains of E.coli have a particular propernsity to invade the urinary tract.
They possess surface fimbriae which bind to surface receptors on the urothelium."

The common cause of transplant rejection

E.coli accounts for 55% of UTL in transplant patients,Recurrent UTL in post renal transplant
patients present with multiple problems including rejection episodes"

Norocin has exellent coverage on E.coli.

Norocin (Norfloxacin) is indicated in UTl especially due to Escherichia coli.


Plant Head Office :
8, Modern Society, Tipu Sultan Road, Karachi, 75350, Pakistan, Tel:0800-26724,(021) 4541876
Fax:(9221)4545915


Email : marketing@bosch-pharma.com
Designed & Developed by Bosch Pharmaceuticals (Pvt.) Ltd.
Copyright © 2004-2005, BOSCH Pharmaceuticals (Pvt.) Ltd., All Rights reserved.

Plant :
Bosch House,221,sector23
korangi Industrial Area,Karachi
Phone :5053103,
Fax:(021)5053104